Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qlosi Quality of Life in Presbyopia
NCT07113210Phase 4Recruiting
- Sponsor
- Southern College of Optometry
- Start
- Jul 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artemether + lumefantrine in presbyopia, sponsored by Southern College of Optometry. Started Jul 2025; status: recruiting.
02
Drugs
artemether + lumefantrine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT07113210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07113210.